Lexicon Pharmaceuticals, Inc. (LXRX)
1.52
-0.13
(-7.88%)
USD |
NASDAQ |
Oct 16, 16:00
1.55
+0.03
(+1.97%)
After-Hours: 20:00
Lexicon Pharmaceuticals Cash from Operations (Quarterly) : -9.192M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -9.192M |
| March 31, 2026 | -14.73M |
| December 31, 2025 | -17.23M |
| September 30, 2025 | -23.83M |
| June 30, 2025 | 16.99M |
| March 31, 2025 | -43.78M |
| December 31, 2024 | -22.80M |
| September 30, 2024 | -53.62M |
| June 30, 2024 | -48.54M |
| March 31, 2024 | -55.13M |
| December 31, 2023 | -50.55M |
| September 30, 2023 | -41.62M |
| June 30, 2023 | -38.12M |
| March 31, 2023 | -31.61M |
| December 31, 2022 | -21.57M |
| September 30, 2022 | -19.44M |
| June 30, 2022 | -24.42M |
| March 31, 2022 | -23.42M |
| December 31, 2021 | -22.83M |
| September 30, 2021 | -17.15M |
| June 30, 2021 | -21.88M |
| March 31, 2021 | -25.16M |
| December 31, 2020 | -34.24M |
| September 30, 2020 | -40.38M |
| June 30, 2020 | -46.30M |
| Date | Value |
|---|---|
| March 31, 2020 | -22.05M |
| December 31, 2019 | -24.37M |
| September 30, 2019 | 190.70M |
| June 30, 2019 | -26.90M |
| March 31, 2019 | -25.62M |
| December 31, 2018 | -27.13M |
| September 30, 2018 | -22.18M |
| June 30, 2018 | -52.52M |
| March 31, 2018 | -46.78M |
| December 31, 2017 | -33.71M |
| September 30, 2017 | -33.96M |
| June 30, 2017 | -32.22M |
| March 31, 2017 | -85.50M |
| December 31, 2016 | -48.79M |
| September 30, 2016 | -35.22M |
| June 30, 2016 | -47.88M |
| March 31, 2016 | -43.74M |
| December 31, 2015 | 265.92M |
| September 30, 2015 | -25.48M |
| June 30, 2015 | -32.18M |
| March 31, 2015 | -23.48M |
| December 31, 2014 | -4.458M |
| September 30, 2014 | -21.19M |
| June 30, 2014 | -19.66M |
| March 31, 2014 | -30.32M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Bristol Myers Squibb Co. | 3.393B |
| ANI Pharmaceuticals, Inc. | 56.67M |
| Corcept Therapeutics, Inc. | 33.54M |
| Veru, Inc. | -5.467M |
| Johnson & Johnson | -- |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -16.46M |
| Cash from Financing (Quarterly) | -0.512M |
| Free Cash Flow | -64.99M |
| Free Cash Flow Per Share (Quarterly) | -0.021 |
| Free Cash Flow to Equity (Quarterly) | -10.73M |
| Free Cash Flow to Firm (Quarterly) | -6.583M |
| Free Cash Flow Yield | -10.93% |